Effect of physostigmine and verapamil on active avoidance in an experimental model of Alzheimer's disease. (Q48686486)

14 February 2018

title

Effect of physostigmine and verapamil on active avoidance in an experimental model of Alzheimer's disease. (English)

1 reference

14 February 2018

1 reference

Popović M

1

1 reference

14 February 2018

Popović N

2

1 reference

14 February 2018

Jovanova-Nesić K

3

1 reference

14 February 2018

Bokonjić D

4

1 reference

14 February 2018

Dobrić S

5

1 reference

14 February 2018

Kostić VS

6

1 reference

14 February 2018

Rosić N

7

1 reference

14 February 2018

publication date

1 June 1997

1 reference

14 February 2018

International Journal of Neuroscience

published in

1 reference

14 February 2018

volume

90

1 reference

14 February 2018

issue

1-2

1 reference

14 February 2018

page(s)

87-97

1 reference

14 February 2018

The cholinergic hypothesis of geriatric memory dysfunction

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00207459709000628

Oral administration of chronic physostigmine does not improve cognitive or mnesic performances in Alzheimer's presenile dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459709000628

Glucose deprivation elicits neurofibrillary tangle-like antigenic changes in hippocampal neurons: prevention by NGF and bFGF

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459709000628

Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459709000628

The role of calcium in cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459709000628

Calcium and the aging nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459709000628

Pharmacological alleviation of cholinergic lesion induced memory deficits in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459709000628

Memory impairments following basal forebrain lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459709000628

Do Calcium Antagonists Have a Place in the Treatment of Mood Disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459709000628

Chronic nimodipine treatment in aged rats: analysis of motor and cognitive effects and muscarinic-induced striatal dopamine release.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459709000628

Prolonged Ca2+-dependent afterhyperpolarizations in hippocampal neurons of aged rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459709000628

Nifedipine and verapamil block the memory-facilitating effect of corticotropin-releasing factor in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459709000628

Reduced calcium uptake by rat brain mitochondria and synaptosomes in response to aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459709000628

Lesions of cholinergic forebrain nuclei: changes in avoidance behavior and scopolamine actions.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459709000628

Neuroprotection against NMDA induced cell death in rat nucleus basalis by Ca2+ antagonist nimodipine, influence of aging and developmental drug treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459709000628

Physostigmine improves water maze performance following nucleus basalis magnocellularis lesions in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459709000628

Altered calcium signaling and neuronal injury: stroke and Alzheimer's disease as examples

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459709000628

Lesioning of the rat basal forebrain leads to memory impairments in passive and active avoidance tasks.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459709000628

Learning and memory deficits after lesions of the nucleus basalis magnocellularis: reversal by physostigmine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459709000628

Learning deficits after unilateral AF64A lesions in the rat basal forebrain: role of cholinergic and noncholinergic systems

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459709000628

Pharmacotherapy in Alzheimer's disease: basis and rationale

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459709000628

Postnatal development of hippocampal and neocortical cholinergic and serotonergic innervation in rat: effects of nitrite-induced prenatal hypoxia and nimodipine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459709000628

Cytosolic free calcium and cell spreading decrease in fibroblasts from aged and Alzheimer donors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459709000628

Behavioral and adaptive status in an experimental model of Alzheimer's disease in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459709000628

Depression of two-way avoidance learning and enhancement of passive avoidance learning by small doses of physostigmine.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459709000628

Effect of physostigmine on memory consolidation and retrieval processes in intact and nucleus basalis-lesioned rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459709000628

Oral physostigmine and lecithin improve memory in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459709000628

Cholinergic drugs reverse AF64A-induced impairment of passive avoidance learning in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459709000628

Oral physostigmine treatment of patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459709000628

10.3109/00207459709000628

21 January 2018

Identifiers

DOI

1 reference

14 February 2018

1 reference

14 February 2018